0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bictegravir Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-8F10171
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Bictegravir Market Research Report 2022
BUY CHAPTERS

Global Bictegravir Market Research Report 2025

Code: QYRE-Auto-8F10171
Report
March 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bictegravir Market

The global market for Bictegravir was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Bictegravir is a potent HIV-1 integrase inhibitor primarily used to treat type 1 AIDS without a history of antiretroviral therapy.
(HIV-1) adult patients, it can also be used as an alternative drug for patients with no history of treatment failure and drug resistance and HIV-1 RNA less than 50copies/ml.
North American market for Bictegravir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bictegravir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bictegravir include Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience, Jiangsu Coben Pharmaceutical, ShenZhen HwaGen Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bictegravir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bictegravir.
The Bictegravir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bictegravir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bictegravir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bictegravir Market Report

Report Metric Details
Report Name Bictegravir Market
Segment by Type
  • 97% - 99%
  • Above 99%
Segment by Application
  • Hospitals
  • Clinics
  • Labs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience, Jiangsu Coben Pharmaceutical, ShenZhen HwaGen Pharmaceutical, Shanghai Haoyuan Chemexpress, Shanghai Systeam Biochem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bictegravir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bictegravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Bictegravir Market report?

Ans: The main players in the Bictegravir Market are Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience, Jiangsu Coben Pharmaceutical, ShenZhen HwaGen Pharmaceutical, Shanghai Haoyuan Chemexpress, Shanghai Systeam Biochem

What are the Application segmentation covered in the Bictegravir Market report?

Ans: The Applications covered in the Bictegravir Market report are Hospitals, Clinics, Labs

What are the Type segmentation covered in the Bictegravir Market report?

Ans: The Types covered in the Bictegravir Market report are 97% - 99%, Above 99%

Recommended Reports

Antiviral Medicines

Anti-Infectives & Disease

HIV & Retroviral Drugs

1 Bictegravir Market Overview
1.1 Product Definition
1.2 Bictegravir by Type
1.2.1 Global Bictegravir Market Value Comparison by Type (2024 VS 2031)
1.2.2 97% - 99%
1.2.3 Above 99%
1.3 Bictegravir by Application
1.3.1 Global Bictegravir Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Global Bictegravir Market Size Estimates and Forecasts
1.4.1 Global Bictegravir Revenue 2020-2031
1.4.2 Global Bictegravir Sales 2020-2031
1.4.3 Global Bictegravir Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bictegravir Market Competition by Manufacturers
2.1 Global Bictegravir Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bictegravir Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bictegravir Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bictegravir, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bictegravir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bictegravir, Product Type & Application
2.7 Global Key Manufacturers of Bictegravir, Date of Enter into This Industry
2.8 Global Bictegravir Market Competitive Situation and Trends
2.8.1 Global Bictegravir Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bictegravir Players Market Share by Revenue
2.8.3 Global Bictegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bictegravir Market Scenario by Region
3.1 Global Bictegravir Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bictegravir Sales by Region: 2020-2031
3.2.1 Global Bictegravir Sales by Region: 2020-2025
3.2.2 Global Bictegravir Sales by Region: 2026-2031
3.3 Global Bictegravir Revenue by Region: 2020-2031
3.3.1 Global Bictegravir Revenue by Region: 2020-2025
3.3.2 Global Bictegravir Revenue by Region: 2026-2031
3.4 North America Bictegravir Market Facts & Figures by Country
3.4.1 North America Bictegravir Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bictegravir Sales by Country (2020-2031)
3.4.3 North America Bictegravir Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bictegravir Market Facts & Figures by Country
3.5.1 Europe Bictegravir Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bictegravir Sales by Country (2020-2031)
3.5.3 Europe Bictegravir Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bictegravir Market Facts & Figures by Region
3.6.1 Asia Pacific Bictegravir Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bictegravir Sales by Region (2020-2031)
3.6.3 Asia Pacific Bictegravir Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bictegravir Market Facts & Figures by Country
3.7.1 Latin America Bictegravir Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bictegravir Sales by Country (2020-2031)
3.7.3 Latin America Bictegravir Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bictegravir Market Facts & Figures by Country
3.8.1 Middle East and Africa Bictegravir Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bictegravir Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bictegravir Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bictegravir Sales by Type (2020-2031)
4.1.1 Global Bictegravir Sales by Type (2020-2025)
4.1.2 Global Bictegravir Sales by Type (2026-2031)
4.1.3 Global Bictegravir Sales Market Share by Type (2020-2031)
4.2 Global Bictegravir Revenue by Type (2020-2031)
4.2.1 Global Bictegravir Revenue by Type (2020-2025)
4.2.2 Global Bictegravir Revenue by Type (2026-2031)
4.2.3 Global Bictegravir Revenue Market Share by Type (2020-2031)
4.3 Global Bictegravir Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bictegravir Sales by Application (2020-2031)
5.1.1 Global Bictegravir Sales by Application (2020-2025)
5.1.2 Global Bictegravir Sales by Application (2026-2031)
5.1.3 Global Bictegravir Sales Market Share by Application (2020-2031)
5.2 Global Bictegravir Revenue by Application (2020-2031)
5.2.1 Global Bictegravir Revenue by Application (2020-2025)
5.2.2 Global Bictegravir Revenue by Application (2026-2031)
5.2.3 Global Bictegravir Revenue Market Share by Application (2020-2031)
5.3 Global Bictegravir Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Sciences Bictegravir Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Company Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cipla Bictegravir Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 Laurus Labs
6.3.1 Laurus Labs Company Information
6.3.2 Laurus Labs Description and Business Overview
6.3.3 Laurus Labs Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Laurus Labs Bictegravir Product Portfolio
6.3.5 Laurus Labs Recent Developments/Updates
6.4 Hetero Drugs Limited
6.4.1 Hetero Drugs Limited Company Information
6.4.2 Hetero Drugs Limited Description and Business Overview
6.4.3 Hetero Drugs Limited Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hetero Drugs Limited Bictegravir Product Portfolio
6.4.5 Hetero Drugs Limited Recent Developments/Updates
6.5 Selleck Chemicals
6.5.1 Selleck Chemicals Company Information
6.5.2 Selleck Chemicals Description and Business Overview
6.5.3 Selleck Chemicals Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Selleck Chemicals Bictegravir Product Portfolio
6.5.5 Selleck Chemicals Recent Developments/Updates
6.6 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical
6.6.1 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Company Information
6.6.2 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Description and Business Overview
6.6.3 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Product Portfolio
6.6.5 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Recent Developments/Updates
6.7 Changzhou Pharmaceutical Factory
6.7.1 Changzhou Pharmaceutical Factory Company Information
6.7.2 Changzhou Pharmaceutical Factory Description and Business Overview
6.7.3 Changzhou Pharmaceutical Factory Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changzhou Pharmaceutical Factory Bictegravir Product Portfolio
6.7.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
6.8 Shanghai Topscience
6.8.1 Shanghai Topscience Company Information
6.8.2 Shanghai Topscience Description and Business Overview
6.8.3 Shanghai Topscience Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai Topscience Bictegravir Product Portfolio
6.8.5 Shanghai Topscience Recent Developments/Updates
6.9 Jiangsu Coben Pharmaceutical
6.9.1 Jiangsu Coben Pharmaceutical Company Information
6.9.2 Jiangsu Coben Pharmaceutical Description and Business Overview
6.9.3 Jiangsu Coben Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu Coben Pharmaceutical Bictegravir Product Portfolio
6.9.5 Jiangsu Coben Pharmaceutical Recent Developments/Updates
6.10 ShenZhen HwaGen Pharmaceutical
6.10.1 ShenZhen HwaGen Pharmaceutical Company Information
6.10.2 ShenZhen HwaGen Pharmaceutical Description and Business Overview
6.10.3 ShenZhen HwaGen Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ShenZhen HwaGen Pharmaceutical Bictegravir Product Portfolio
6.10.5 ShenZhen HwaGen Pharmaceutical Recent Developments/Updates
6.11 Shanghai Haoyuan Chemexpress
6.11.1 Shanghai Haoyuan Chemexpress Company Information
6.11.2 Shanghai Haoyuan Chemexpress Description and Business Overview
6.11.3 Shanghai Haoyuan Chemexpress Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Haoyuan Chemexpress Bictegravir Product Portfolio
6.11.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates
6.12 Shanghai Systeam Biochem
6.12.1 Shanghai Systeam Biochem Company Information
6.12.2 Shanghai Systeam Biochem Description and Business Overview
6.12.3 Shanghai Systeam Biochem Bictegravir Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Systeam Biochem Bictegravir Product Portfolio
6.12.5 Shanghai Systeam Biochem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bictegravir Industry Chain Analysis
7.2 Bictegravir Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bictegravir Production Mode & Process Analysis
7.4 Bictegravir Sales and Marketing
7.4.1 Bictegravir Sales Channels
7.4.2 Bictegravir Distributors
7.5 Bictegravir Customer Analysis
8 Bictegravir Market Dynamics
8.1 Bictegravir Industry Trends
8.2 Bictegravir Market Drivers
8.3 Bictegravir Market Challenges
8.4 Bictegravir Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Bictegravir Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bictegravir Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bictegravir Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bictegravir Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Bictegravir Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bictegravir Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bictegravir Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bictegravir Average Price (K US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bictegravir, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bictegravir, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bictegravir, Product Type & Application
 Table 12. Global Key Manufacturers of Bictegravir, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bictegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bictegravir as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bictegravir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bictegravir Sales by Region (2020-2025) & (Tons)
 Table 18. Global Bictegravir Sales Market Share by Region (2020-2025)
 Table 19. Global Bictegravir Sales by Region (2026-2031) & (Tons)
 Table 20. Global Bictegravir Sales Market Share by Region (2026-2031)
 Table 21. Global Bictegravir Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bictegravir Revenue Market Share by Region (2020-2025)
 Table 23. Global Bictegravir Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bictegravir Revenue Market Share by Region (2026-2031)
 Table 25. North America Bictegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bictegravir Sales by Country (2020-2025) & (Tons)
 Table 27. North America Bictegravir Sales by Country (2026-2031) & (Tons)
 Table 28. North America Bictegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bictegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bictegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bictegravir Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Bictegravir Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Bictegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bictegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bictegravir Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bictegravir Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Bictegravir Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Bictegravir Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bictegravir Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bictegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bictegravir Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Bictegravir Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Bictegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bictegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bictegravir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bictegravir Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Bictegravir Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Bictegravir Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bictegravir Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bictegravir Sales (Tons) by Type (2020-2025)
 Table 51. Global Bictegravir Sales (Tons) by Type (2026-2031)
 Table 52. Global Bictegravir Sales Market Share by Type (2020-2025)
 Table 53. Global Bictegravir Sales Market Share by Type (2026-2031)
 Table 54. Global Bictegravir Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bictegravir Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bictegravir Revenue Market Share by Type (2020-2025)
 Table 57. Global Bictegravir Revenue Market Share by Type (2026-2031)
 Table 58. Global Bictegravir Price (K US$/Ton) by Type (2020-2025)
 Table 59. Global Bictegravir Price (K US$/Ton) by Type (2026-2031)
 Table 60. Global Bictegravir Sales (Tons) by Application (2020-2025)
 Table 61. Global Bictegravir Sales (Tons) by Application (2026-2031)
 Table 62. Global Bictegravir Sales Market Share by Application (2020-2025)
 Table 63. Global Bictegravir Sales Market Share by Application (2026-2031)
 Table 64. Global Bictegravir Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bictegravir Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bictegravir Revenue Market Share by Application (2020-2025)
 Table 67. Global Bictegravir Revenue Market Share by Application (2026-2031)
 Table 68. Global Bictegravir Price (K US$/Ton) by Application (2020-2025)
 Table 69. Global Bictegravir Price (K US$/Ton) by Application (2026-2031)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 73. Gilead Sciences Bictegravir Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. Cipla Company Information
 Table 76. Cipla Description and Business Overview
 Table 77. Cipla Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 78. Cipla Bictegravir Product
 Table 79. Cipla Recent Developments/Updates
 Table 80. Laurus Labs Company Information
 Table 81. Laurus Labs Description and Business Overview
 Table 82. Laurus Labs Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 83. Laurus Labs Bictegravir Product
 Table 84. Laurus Labs Recent Developments/Updates
 Table 85. Hetero Drugs Limited Company Information
 Table 86. Hetero Drugs Limited Description and Business Overview
 Table 87. Hetero Drugs Limited Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 88. Hetero Drugs Limited Bictegravir Product
 Table 89. Hetero Drugs Limited Recent Developments/Updates
 Table 90. Selleck Chemicals Company Information
 Table 91. Selleck Chemicals Description and Business Overview
 Table 92. Selleck Chemicals Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 93. Selleck Chemicals Bictegravir Product
 Table 94. Selleck Chemicals Recent Developments/Updates
 Table 95. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Company Information
 Table 96. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Description and Business Overview
 Table 97. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 98. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Product
 Table 99. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Recent Developments/Updates
 Table 100. Changzhou Pharmaceutical Factory Company Information
 Table 101. Changzhou Pharmaceutical Factory Description and Business Overview
 Table 102. Changzhou Pharmaceutical Factory Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 103. Changzhou Pharmaceutical Factory Bictegravir Product
 Table 104. Changzhou Pharmaceutical Factory Recent Developments/Updates
 Table 105. Shanghai Topscience Company Information
 Table 106. Shanghai Topscience Description and Business Overview
 Table 107. Shanghai Topscience Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 108. Shanghai Topscience Bictegravir Product
 Table 109. Shanghai Topscience Recent Developments/Updates
 Table 110. Jiangsu Coben Pharmaceutical Company Information
 Table 111. Jiangsu Coben Pharmaceutical Description and Business Overview
 Table 112. Jiangsu Coben Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 113. Jiangsu Coben Pharmaceutical Bictegravir Product
 Table 114. Jiangsu Coben Pharmaceutical Recent Developments/Updates
 Table 115. ShenZhen HwaGen Pharmaceutical Company Information
 Table 116. ShenZhen HwaGen Pharmaceutical Description and Business Overview
 Table 117. ShenZhen HwaGen Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 118. ShenZhen HwaGen Pharmaceutical Bictegravir Product
 Table 119. ShenZhen HwaGen Pharmaceutical Recent Developments/Updates
 Table 120. Shanghai Haoyuan Chemexpress Company Information
 Table 121. Shanghai Haoyuan Chemexpress Description and Business Overview
 Table 122. Shanghai Haoyuan Chemexpress Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 123. Shanghai Haoyuan Chemexpress Bictegravir Product
 Table 124. Shanghai Haoyuan Chemexpress Recent Developments/Updates
 Table 125. Shanghai Systeam Biochem Company Information
 Table 126. Shanghai Systeam Biochem Description and Business Overview
 Table 127. Shanghai Systeam Biochem Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2020-2025)
 Table 128. Shanghai Systeam Biochem Bictegravir Product
 Table 129. Shanghai Systeam Biochem Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Bictegravir Distributors List
 Table 133. Bictegravir Customers List
 Table 134. Bictegravir Market Trends
 Table 135. Bictegravir Market Drivers
 Table 136. Bictegravir Market Challenges
 Table 137. Bictegravir Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bictegravir
 Figure 2. Global Bictegravir Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bictegravir Market Share by Type: 2024 & 2031
 Figure 4. 97% - 99% Product Picture
 Figure 5. Above 99% Product Picture
 Figure 6. Global Bictegravir Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bictegravir Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Labs
 Figure 11. Global Bictegravir Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Bictegravir Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Bictegravir Sales (2020-2031) & (Tons)
 Figure 14. Global Bictegravir Average Price (K US$/Ton) & (2020-2031)
 Figure 15. Bictegravir Report Years Considered
 Figure 16. Bictegravir Sales Share by Manufacturers in 2024
 Figure 17. Global Bictegravir Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Bictegravir Players: Market Share by Revenue in Bictegravir in 2024
 Figure 19. Bictegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Bictegravir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Bictegravir Sales Market Share by Country (2020-2031)
 Figure 22. North America Bictegravir Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Bictegravir Sales Market Share by Country (2020-2031)
 Figure 26. Europe Bictegravir Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Bictegravir Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Bictegravir Revenue Market Share by Region (2020-2031)
 Figure 34. China Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Bictegravir Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Bictegravir Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Bictegravir Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Bictegravir Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Bictegravir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Bictegravir by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Bictegravir by Type (2020-2031)
 Figure 56. Global Bictegravir Price (K US$/Ton) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Bictegravir by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Bictegravir by Application (2020-2031)
 Figure 59. Global Bictegravir Price (K US$/Ton) by Application (2020-2031)
 Figure 60. Bictegravir Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart